1,028 results on '"Carvalho, Edgar M."'
Search Results
2. Assessment of immune and clinical response in patients with mucosal leishmaniasis treated with pentavalent antimony and pentoxifylline
3. Profile of T and B lymphocytes in individuals resistant to Schistosoma mansoni infection
4. In Situ versus Systemic Immune Response in the Pathogenesis of Cutaneous Leishmaniasis
5. Short communication: The miR-155a-5p is correlated with increased ROS and impaired apoptosis in macrophages infected by Leishmania braziliensis
6. MicroRNAs regulating macrophages infected with Leishmania L. (V.) Braziliensis isolated from different clinical forms of American tegumentary leishmaniasis
7. Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis
8. Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial
9. Multi-omic Analyses of Plasma Cytokines, Lipidomics, and Transcriptomics Distinguish Treatment Outcomes in Cutaneous Leishmaniasis
10. Improved Treatment Outcome Following the Use of a Wound Dressings in Cutaneous Leishmaniasis Lesions.
11. Multiomic profiling of cutaneous leishmaniasis infections reveals microbiota-driven mechanisms underlying disease severity
12. Regulatory T cells control Staphylococcus aureus and disease severity of cutaneous leishmaniasis
13. Leishmania braziliensis exosomes activate human macrophages to produce proinflammatory mediators
14. Prostaglandin e2 contributes to L. braziliensis survival and therapeutic failure in cutaneous leishmaniasis
15. Investigation of the pathways related to intrinsic miltefosine tolerance in Leishmania (Viannia) braziliensis clinical isolates reveals differences in drug uptake
16. Neurologic, clinical, and immunologic features in a cohort of HTLV-1 carriers with high proviral loads
17. Forecasting temporal dynamics of cutaneous leishmaniasis in Northeast Brazil.
18. NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis
19. Clinical Profile and Diagnosis of Recurrent Cutaneous Leishmaniasis
20. Dogs Harbor Leishmania braziliensis and Participate in the Transmission Cycle of Human Tegumentary Leishmaniasis
21. Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy
22. IL-1β Production by Intermediate Monocytes Is Associated with Immunopathology in Cutaneous Leishmaniasis
23. Onabotulinumtoxin type A improves lower urinary tract symptoms and quality of life in patients with human T cell lymphotropic virus type 1 associated overactive bladder
24. Impaired TNF, IL-1β, and IL-17 production and increased susceptibility to Mycobacterium tuberculosis infection in HTLV-1 infected individuals
25. Influence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis
26. Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial
27. Staphylococcus aureuspromotes increase IL-1 mediated immunopathology and delayed healing in cutaneous leishmaniasis
28. Regulatory T cells limit opportunistic colonization of Staphylococcus aureusto promote lesion resolution in cutaneous leishmaniasis
29. Correction: Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial
30. Selective whole-genome amplification reveals population genetics of Leishmania braziliensis directly from patient skin biopsies
31. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
32. Onabotulinumtoxin type A improves lower urinary tract symptoms and quality of life in patients with human T cell lymphotropic virus type 1 associated overactive bladder
33. Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial
34. Evolution of erectile dysfunction in individuals infected with human T-lymphotropic virus 1: a prospective cohort study
35. The skin microbiome enhances disease through IL-1b and delays healing in cutaneous leishmaniasis patients
36. Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study
37. Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B
38. Dogs Harbor Leishmania braziliensis and Participate in the Transmission Cycle of Human Tegumentary Leishmaniasis.
39. Blood cytokines in atopic and non‐atopic eosinophilic moderate to severe asthmatics
40. TNF-induced metalloproteinase-9 production is associated with neurological manifestations in HTLV-1-infected individuals
41. Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins
42. Selective whole-genome amplification reveals population genetics of Leishmania braziliensis directly from patient skin biopsies
43. Interleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies
44. Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)–Infected Individuals Without HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study
45. Tr-1-Like CD4⁺CD25⁻CD127 -/low FOXP3⁻ Cells Are the Main Source of Interleukin 10 in Patients With Cutaneous Leishmaniasis Due to Leishmania braziliensis
46. Intermediate Monocytes Contribute to Pathologic Immune Response in Leishmania braziliensis Infections
47. Sistema de Informação Contabilístico e Fiscal: Análise Comparativa entre Portugal e a Guiné-Bissau
48. Pioglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Downregulates the Inflammatory Response in Cutaneous Leishmaniasis Patients Without Interfering in Leishmania braziliensis Killing by Monocytes
49. Leishmania braziliensis causing human disease in Northeast Brazil presents loci with genotypes in long-term equilibrium
50. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.